Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 5, Issue 4 (2016)

Clinical efficacy of omega-3 polyunsaturated fatty acids and rosuvastatin in combination therapy for patients with psoriasis and metabolic syndrome

Author(s):
N Virstyuk, М Nykyforuk
Abstract:
Based on the examination and treatment of 100 patients with moderate psoriasis associated with metabolic syndrome, it was established that the use of narrowband UVB-therapy combined with rosuvastatin and omega-3 polyunsaturated fatty acids in combination therapy contributes to the improvement of the efficacy of therapy for dermatosis, induces a long-term remission and improves the life quality of patients.
Pages: 90-92  |  1028 Views  23 Downloads
How to cite this article:
N Virstyuk, М Nykyforuk. Clinical efficacy of omega-3 polyunsaturated fatty acids and rosuvastatin in combination therapy for patients with psoriasis and metabolic syndrome. Pharma Innovation 2016;5(4):90-92.
The Pharma Innovation Journal